Long-term outcomes
MPM
All patients received subsequent other therapies as determined by treating physician following participation in the trial. Among all patients, median overall survival (OS) was 19.5 months. The median OS among patients who had MPM was 22 months (Overall survival of patients following Olvi-vec therapy.